Common Stock and Stockholders' Equity (Tables)

9 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of Stock Option and RSU Award Activities

The following table summarizes the Company’s stock option and RSU award activities for the nine months ended December 31, 2019 (in thousands, except exercise price, contractual term and fair value information):

	Options Outstanding						RSUs Outstanding
	Number of Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value		Number of Shares	Weighted- Average Grant Date Fair Value		Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Outstanding - April 1, 2019	2,751	$	35.10	6.3	$	176,002	2,419	$	76.34	3.0	$	238,734
Stock options granted	779	75.87
RSUs granted							1,889	71.03
Stock options exercised	(267)	25.39			13,835
RSUs vested							(650)	64.29
Stock options canceled/forfeited	(220)	79.90
RSUs canceled/forfeited							(408)	76.73
Outstanding - December 31, 2019	3,043	$	43.15	5.9	$	87,479	3,250	$	75.62	2.8	$	213,517

Schedule of Stock-based Compensation Expense Attributed to Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):

	Three Months Ended December 31,				Nine Months Ended December 31,
	2019		2018		2019		2018
Cost of revenue	$	1,315	$	934	$	3,837	$	2,522
Research and development	8,611		4,322		23,073		11,443
Sales and marketing	11,090		6,222		30,682		17,040
General and administrative	4,934		3,286		12,904		8,619
Total stock-based compensation expense	$	25,950	$	14,764	$	70,496	$	39,624